Engineering Recombinantly Expressed Antiviral Lectins
Aug 30, 2023•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Cyanovirin-N, or CV-N for short, is a broadly binding molecule to glycopeptides and glycan structures on viral envelope spikes, which allows for screening of these structures by protein-interaction based sensor technologies.
Dr. Irene Maier, Lecturer at the Medical University of Vienna, Austria, examines the molecular understanding of immune diseases. Maier has designed new antiviral CV-N variants and measured their binding constants to glycoproteins exposed at the surface of immune-stimulating cells, which has the potential to revolutionize treatments against viral infections.
Find out more about Irene's work on ResearchGate
Read the original research: https://www.jove.com/de/t/63541/engineering-antiviral-agents-via-surface-plasmon-resonance
For the best experience, listen in Metacast app for iOS or Android